Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Archives Des Maladies Du Coeur Et Des Vaisseaux|June 1, 1995
[Efficacy and safety of thrombolytic therapy in the elderly with severe pulmonary embolism]N Meneveau, F Schiele, Y Bouras, et al.
Heart (British Cardiac Society)|July 1, 1997
Planimetry of aortic valve area using multiplane transoesophageal echocardiography is not a reliable method for assessing severity of aortic stenosisY Bernard, N Meneveau, A Vuillemenot, et al.
Presse Medicale (Paris, France : 1983)|May 4, 1996
[Anticoagulant therapy with recombinant hirudin in patients with thrombopenia induced by heparin]F Schiele, A Vuillemenot, T Mouhat, et al.
American Journal of Hematology|September 1, 1995
Use of recombinant hirudin as antithrombotic treatment in patients with heparin-induced thrombocytopeniaF Schiele, A Vuillemenot, P Kramarz, et al.
The American Journal of Cardiology|December 5, 1991
Use of left ventricular function as an end point of thrombolytic therapyJ P Bassand, T Anguenot, J Cassagnes, et al.
European Heart Journal|July 1, 1991
Percutaneous mitral valvulotomy in non-optimal candidatesY Bernard, J P Bassand, F Schiele, et al.
Journal of the American College of Cardiology|October 1, 1992
Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years oldY Bernard, J Etievent, J L Mourand, et al.
Echocardiography (Mount Kisco, N.Y.)|March 23, 2001
Lack of agreement between left ventricular volumes and ejection fraction determined by two-dimensional echocardiography and contrast cineangiography in postinfarction patientsY Bernard, N Meneveau, S Boucher, et al.
Journal of the American College of Cardiology|October 1, 1991
The double-balloon and Inoue techniques in percutaneous mitral valvuloplasty: comparative results in a series of 232 casesJ P Bassand, F Schiele, Y Bernard, et al.
Journal of the American College of Cardiology|April 1, 1989
Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular functionJ P Bassand, J Machecourt, J Cassagnes, et al.
Pageof 3